Institut Bordet - Retour à la page d'accueil
en
I want to donate to research

Search the site

Type de publication

Lung and thorax cancers

Lung and thorax cancers “The therapeutic strategy depends on the type of cancer, its extent and the patient’s general state of health.”  Dr Thierry Berghmans, Head of the Thoracic Oncology Clinic How we treat cancers of the lungs and thoracic cavity Thanks to extensive internal and external collaboration, the Institut Bordet is able to treat all cancers of the thoracic cavity, including lung cancer.Several types of cancer can develop in the thorax: small and large cell lung (or “bronchial”) cancer, pulmonary metastases originating in other primary tumours and rare tumours such as cancer of the thymus, mesothelioma, pleura, etc. ...

Prostate cancers

Prostate cancers “Our aim is to preserve the patient’s quality of life while treating the tumour as effectively as possible.”   Dr Alexandre Peltier, Urological surgeon How we treat the prostate cancers Prostate cancer is the most common cancer in men. The Institut Jules Bordet has the cutting-edge technology needed to detect and treat these tumours. ...

Head and neck cancers

Head and neck cancers « Providing comprehensive care for the patient is important for our multidisciplinary team but equally important is providing it without delay ... »  Delphine Talmon, Oncological Care Coordinating Nurse (ICSO) How we treat ENT cancers of the head and neck Head and neck cancers include all tumours that develop in the upper aerodigestive tract and ENT (ear, nose and throat) system: tongue, cheek, palate, nose, sinuses, salivary glands, larynx, pharynx, etc. ...

Colorectal cancers

Colorectal cancers “Our philosophy is to care for patients while sparing them any pointless and difficult treatments.”   Dr Alain Hendlisz, Coordinator of the Digestive Tumour CMO, Institut Bordet How we treat cancers of the colon or rectum Colorectal cancers are among the most common forms of cancer. Significant advances have been made in improving the way they are treated. Treatment requires a multidisciplinary approach. ...

Thyroid cancers

Thyroid cancers “The therapeutic strategy depends largely on the risk of persistence or recurrence of the disease.”  Dr Giuseppe Costante, Endocrinologist and Head of Thyroid Cancer at the EURACAN Project. How we treat thyroid cancers The Institut Jules Bordet treats all types of thyroid cancer. The great majority can be cured but require correct assessment of the risk of recurrence and follow-up care for life. ...

Gynaecological cancers

Gynaecological cancers How we treat gynaecological cancers The term gynaecological cancer covers cancers of the endometrium, the ovaries, the cervix, the vulva and the vagina. These intimate cancers require multidisciplinary, personalised care and treatment. Diagnosis – examinations required ...

Bone and soft tissue cancers

Bone and soft tissue cancers How we treat bone and soft tissue cancers The medical team at the Institut Jules Bordet treats tumours that appear in the soft tissue (muscles, fat, nerves, blood vessels, etc), primary bone cancer in children (in close collaboration with HUDERF – the Hôpital Universitaire des Enfants Reine Fabiola) and in adults as well as bone metastases.  ...

Liver cancers

Liver cancers “A surgeon never takes the decision to operate on their own. The management of hepatic tumours is always multidisciplinary.”  Dr Vincent Donckier, Hepatobiliary surgeon and head of surgery, Institut Bordet. How we treat liver cancers There are 2 types of hepatic cancer: primary liver cancer and hepatic metastases originating from other primary tumours. Surgery is the major treatment for these cancers but it is limited by the need to conserve sufficient functional liver tissue. Other therapies may be combined with surgery. ...

Urological and male genital cancers

Urological and male genital cancers “Our patients are supported by a team of medical and paramedical specialists.”      Dr Alexandre Peltier, UROLOGICAL SURGEON How we treat male urological and genital cancers Urogenital cancers are tumours that develop in the urinary or genital system. ...

Brain tumours

Brain tumours « Neuro-Oncology is above all a multidisciplinary approach at the centre of which the quality of life of the patient is crucial »  Dr Philippe Martinive Clinic Director How we treat brain tumours The Institut Jules Bordet treats both primary brain cancers and brain metastases. Medical imaging plays a major role in this treatment because, in the brain, accurate definition of the tumour is crucial. ...

Neuroendocrine tumours

Neuroendocrine tumours “A neuroendocrine tumour is a particular kind of digestive cancer that requires very specific management.”  Dr Alain Hendlisz, Coordinator of the Digestive Tumour CMO, Institut Bordet. How we treat neuroendocrine tumours Although often situated in an organ of the digestive tract, neuroendocrine tumours behave differently from other digestive cancers and must often be treated in a specific way. ...

Urology

Urology department Our role The Urology Department is responsible for the medical and surgical treatment of pathologies associated with the male and female urinary tract and the male genitalia.Its activities are essentially diagnosis and treatment and the monitoring of cancerous and non-cancerous conditions affecting the prostate, kidneys, bladder and male genitalia.As our work is principally ...

Molecular Immunology Laboratory

Molecular Immunology Laboratory (MIU) Overview The Molecular Immunology Laboratory strives to improve our understanding of the immune response in cancer and how it can be manipulated to the benefit of the patients. It investigates lymphocyte activities in several clinical conditions: First, by studying the organization and cellular state of CD4+ T cells and germinal center B cells infiltrating...

Laboratory of Oncology and Experimental Surgery (LOCE)

Laboratory of Oncology and Experimental Surgery (LOCE) Description The Laboratory of Oncology and Experimental Surgery (LOCE) is a laboratory at the Institut Bordet recognised by the ULB Faculty of Medicine. It specialises in research into malignant melanoma and pigment cells in general. It combines fundamental research with preclinical and translational research. The LOCE has a self-contained...

Protection of privacy

Information notice concerning the protection of your personal data Protection of privacy The Jules Bordet Institute (hereinafter "The Institution") is committed to providing you, as a patient and independently of your income, your insurability status, your origins or your philosophical beliefs, with the best possible welcome, optimal medical and paramedical care and appropriate socia...

Movember 2022

Movember 2022     November is the male cancer awareness month. The Brussels University Hospital support the Movember initiative and remind the importance of cancer screening for men The latest on preventing and screening for male cancers ...

Radiation protection department

Radiation protection department - RPD Our team Composition Head of Radiation protection departmentYimo Wadje MarieRPO EffectiveMoschidis ThéoRPO Radiotherapy...

Access and practical information New Jules Bordet Institute

The Jules Bordet Institute is moving! How to get to the new Institute? From 28 November 2021, the Jules Bordet Institute is moving to the Erasmus campus in Anderlecht. From this date all the Institute's activities will take place at Rue Meylemeersh n°90, 1070 Anderlecht. To get to the new In...

Facturation FAQ

Question about an invoice ? Do you have a question about the content of the invoice received?Before contacting our services we suggest you consult the “FAQ” section that lists the most frequently asked questions followed by the clear and precise answers given by the Invoicing Department. I have received an invoice but I paid for the consultation on the spot ...

Access old bordet

Accessibility and contact Institut Jules Bordet How to get there Address Institut Jules Bordet: 121-125,  boulevard de Waterloo – 1000 Brussels   Phone number +32 (0)2 541 31 11 ...